{
  "ptid_time": "135_S_4356_2011-11-10",
  "img_path": "/data/qiuhui/data/adni/images/135_S_4356/2011-11-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 14,315 mm³, 52.3% below the reference mean. With a Z-score of -1.24 (10.7th percentile), this represents mild atrophy; hippocampal volume measures 8,764 mm³, 9.2% above the reference mean. With a Z-score of 0.92 (82.1th percentile), this represents normal volume ; whole brain volume measures 1,103,570 mm³, 2.7% below the reference mean. With a Z-score of -0.39 (35.0th percentile), this represents normal volume ; entorhinal cortex volume measures 5,290 mm³, 24.1% above the reference mean. With a Z-score of 1.67 (95.2th percentile), this represents moderate enlargement; fusiform gyrus volume measures 18,900 mm³, 5.1% below the reference mean. With a Z-score of -0.42 (33.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,446 mm³, 4.3% below the reference mean. With a Z-score of -0.35 (36.1th percentile), this represents normal volume . ",
  "text_data": "Age is 68.1 years. Gender is Male. Education: 20 years. Handedness: Left. Race: White. Medical history: Neurologic; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Malignancy. MMSE: 28.0. MoCA: 26.0. Logical Memory: 9.0. Laboratory findings: Phosphorus: 2.30 (significant reduced). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.08 SUVR (normal ); Total tau: 553.50 pg/mL (profound elevated); Phosphorylated tau: 52.30 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain imaging shows mild ventricular atrophy but otherwise normal or even enlarged volumes in key regions (hippocampus, entorhinal cortex). Cognitive scores (MMSE 28, MoCA 26) are within normal limits, but CSF biomarkers (profoundly elevated T-tau and P-tau) strongly suggest Alzheimer's pathology despite normal amyloid PET (AV45). This discrepancy may indicate early tauopathy without significant amyloid burden.  \n\n**Diagnosis:** **MCI** (biomarker evidence of neurodegeneration with preserved cognition)  \n**Confidence:** **Medium** (conflicting biomarkers—tau elevation without amyloid or significant atrophy—warrant caution; clinical follow-up is needed to track progression).",
  "timestamp": "2025-07-26T15:33:59.985059"
}